Critical Commentary on "Gut-to-brain signaling restricts dietary protein intake during recovery from catabolic states" in Cell 2025

This scholarly commentary critically evaluates the study by Jaschke et al., “Gut-to-brain signaling restricts dietary protein intake during recovery from catabolic states” (Cell, 2025). The original article proposes a nutrient-specific enteroendocrine–vagal–NTS–PVN signaling axis that selectively suppresses protein intake during catabolic recovery. While conceptually provocative, the evidence presented in the paper displays substantial methodological limitations, missing controls, and interpretive overreach.

Our analysis provides a comprehensive, figure-by-figure critique of all main Figures (1–7), Extended Data Figures (ED1–ED15), and Supplementary Figures (S1–S12). Behavioral assays often reflect general hypophagia rather than protein-specific avoidance. Palatability, sickness, and texture controls are insufficient, undermining claims of nutrient-selective behavior. The purported gut-derived signaling molecule remains unidentified; neither peptide purification nor receptor identification is provided. scRNA-seq datasets are underpowered and do not convincingly isolate a “protein-responsive” enteroendocrine subtype.

Neural circuit data—including vagal tracing, NTS activation, and PVN involvement—lack the specificity required to support a dedicated protein-avoidance pathway. Many manipulations (chemogenetic, optogenetic, viral) likely affect general satiety circuits rather than nutrient-selective pathways. Physiological interpretation, particularly the claim that suppressing protein intake is adaptive during catabolic recovery, contradicts established metabolic principles and lacks biochemical correlates.

This commentary highlights these conceptual and technical concerns to promote rigorous discussion and future mechanistic clarity. Understanding nutrient-specific gut–brain signaling remains an important frontier, but acceptance of a specialized protein-avoidance circuit requires stronger behavioral, molecular, and neurophysiological evidence than is currently provided.